Safe Medicine ?

DRUG LAWS & POLICY INJECTIONS

Government To Create A Separate Ministry For Medical Devices: Ananth KumarBengaluru, 19 Feb 2018: The Indian Medical Device Industry is enthused to learn of huge opportunities coming up through the Government’s envisaged program Modicare aimed at providing Universal Healthcare Coverage to 500 million people. Inaugurating the 3rd Global Conference on Pharma Industry and Medical Devices today at Bengaluru, Union Minister for chemicals & Fertilizers. Ananth Kumar reiterated that the government’s flagship program, Modicare will unleash huge growth opportunities and challenges for the Indian pharma sector through explosive demand.

NPPA's Directive To Hospitals To Mention Cost Of Consumables To Help Check Prices Of Consumables Used In AngioplastyNew Delhi, 14 Feb 2018: The National Pharmaceutical Pricing Authority’s (NPPA) decision to direct healthcare institutions to mention the cost of main consumables during angioplasty procedure will help increase transparency in hospital billing and reduce treatment cost for patients, say healthcare activists and advocacy groups.

Delhi Medical Council To Conduct Survey In Delhi To Estimate The Number Of QuacksNew Delhi, 19 Feb 2018: The Delhi Medical Council (DMC), as statutory body that governs the practice of modern medicine in the state, will undertake survey to estimate the number of quacks in the city. Till now, the council has been going with a rough figure of 50,000, although officials remain unaware of how the figure was arrived at.

PIL In HC For Modern Blood Testing SystemCuttack, 12 Feb 2018: A public interest litigation has sought Orissa High Court's intervention to introduce Nucleic Acid Testing-Polymerase Chain Reaction (NAT-PCR) blood testing facility at all blood banks in the state.

NPPA Revises Ceiling Prices Of Nine FormulationsNEW DELHI, 13 FEB 2018: The National Pharmaceutical Pricing Authority has revised upwards the ceiling prices of nine scheduled formulations used to treat a range of ailments from infertility in women and arthritis to seizures. The price of Clomiphene tablet 50mg (1 tablet) has been raised to ₹7.56 from ₹6.76, while a 100-mg tablet is now priced at ₹11.08 up from ₹10.62.

CDRI To Unveil Osteoporosis MedicineLUCKNOW, 17 FEB 2018: At its 67th Annual Day on Saturday, Central Drugs Research Institute (CDRI) will launch its anti-osteoporosis agent. This medical formulation developed by CDRI's bone biology department will help prevent glucocorticoid-induced osteoporosis - a type of osteoporosis caused by medication. Glucocorticoid is a class of steroid hormones present in some medicines which leads to this type of osteoporosis.

PHARMA INJECTIONS

Online Pharmacy Medlife Launches Private Label Generic DrugsBengaluru, 12 Feb 2018: Online pharmacy Medlife is launching its private label generic drugs 'Pure Generics'. The company is looking to launch about 30 generic drugs and 40 Over-The-Counter (OTC) products by the next financial year.

Big Data To Help Online Pharmacies Stay In ShapeBENGALURU, 16 FEB 2018: Epharmacy 1mg Technologies’ chief executive Prashant Tandon has set up a small team of data scientists whose only job is to tinker around with available data and come up with interesting models with a potential to be turned into products in the near future.

US FDA Lifts Warning Letter Issued To USV’s Daman FacilityMumbai, Feb 20, 2018: The drug firm, USV Private Ltd. said today that the US Food and Drug Administration (USFDA) lifted its warning letter issued in March 2017 to the Daman facility, following corrective actions taken by the company. USV Daman manufactures aseptic and oral solid dosage products for the US market.

Pharma Units To Face Action For Failed SamplesSHIMLA, 15 FEB 2018: Himachal Pradesh health minister Vipin Parmar said the state government would take stern action against drug manufacturers whose samples had failed the quality test recently.

MTP Kits Being Sold Illegally In Raigad DistrictNavi Mumbai, 15 Feb 2018: The Raigad Pharmacist Forum has alleged that kits for medical termination of pregnancy (MTP) are being sold illegally across the district. A group of operators from Mumbai allegedly bring kits from outside the state and sell it to doctors in rural areas.\

61% Stents Used Last Year Were Made In IndiaNew Delhi, 14 Feb 2018: If National Pharmaceuticals Pricing Authority (NPPA) chairman Bhupendra Singh’s tweet on Tuesday afternoon is any indication, the ‘Make in India’ slogan has truly worked for stents. A day after he announced a further cut in stent prices, Singh said 61% of the stents distributed in the country in 2017 were manufactured by Indian companies.